Cryo-EM structure of the human somatostatin receptor 2 complex with its agonist somatostatin delineates the ligand binding specificity

  1. Yunseok Heo
  2. Eojin Yoon
  3. Ye-Eun Jeon
  4. Ji-Hye Yun
  5. Naito Ishimoto
  6. Hyeonuk Woo
  7. Sam-Yong Park
  8. Ji-Joon Song  Is a corresponding author
  9. Weontae Lee  Is a corresponding author
  1. Yonsei University, Republic of Korea
  2. Korea Advanced Institute of Science and Technology, Republic of Korea
  3. Yokohama City University, Japan
  4. Seoul National University, Republic of Korea

Abstract

Somatostatin is a peptide hormone that regulates endocrine systems by binding to G-protein-coupled somatostatin receptors. Somatostatin receptor 2 (SSTR2) is a human somatostatin receptor and is highly implicated in hormone disorders, cancers and neurological diseases. Here, we report the high resolution cryo-EM structure of full-length human SSTR2 bound to the agonist somatostatin (SST-14) in complex with inhibitory G (Gi) proteins. Our structural and mutagenesis analyses show that seven transmembrane helices form a deep pocket for ligand binding and that SSTR2 recognizes the highly conserved Trp-Lys motif of SST-14 at the bottom of the pocket. Furthermore, our sequence analysis combined with AlphaFold modeled structures of other SSTR isoforms provide a structural basis for the mechanism by which SSTR family proteins specifically interact with their cognate ligands. This work provides the first glimpse into the molecular recognition mechanism of somatostatin receptors and a crucial resource to develop therapeutics targeting somatostatin receptors.

Data availability

The cryo-EM map and the model are to be deposited at EMDB (www.ebi.ac.uk) and RCSB (www.rcsb.org) data base with the accession codes of EMD-32543 and 7WJ5, respectively.

The following data sets were generated

Article and author information

Author details

  1. Yunseok Heo

    Department of Biochemistry, Yonsei University, Seoul, Republic of Korea
    Competing interests
    No competing interests declared.
  2. Eojin Yoon

    Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
    Competing interests
    No competing interests declared.
  3. Ye-Eun Jeon

    Department of Biochemistry, Yonsei University, Seoul, Republic of Korea
    Competing interests
    No competing interests declared.
  4. Ji-Hye Yun

    Department of Biochemistry, Yonsei University, Seoul, Republic of Korea
    Competing interests
    Ji-Hye Yun, is an employee at PCG-Biotech and holds a research director position..
  5. Naito Ishimoto

    Drug Design Laboratory, Yokohama City University, Yokohama, Japan
    Competing interests
    No competing interests declared.
  6. Hyeonuk Woo

    Department of Chemistry, Seoul National University, Seoul, Republic of Korea
    Competing interests
    No competing interests declared.
  7. Sam-Yong Park

    Drug Design Laboratory, Yokohama City University, Yokohama, Japan
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6164-8896
  8. Ji-Joon Song

    Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
    For correspondence
    songj@kaist.ac.kr
    Competing interests
    Ji-Joon Song, is a co-founder of PCG-Biotech.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7120-6311
  9. Weontae Lee

    Department of Biochemistry, Yonsei University, Seoul, Republic of Korea
    For correspondence
    wlee@spin.yonsei.ac.kr
    Competing interests
    Weontae Lee, is a co-founder of PCG-Biotech.

Funding

National Research Foundation of Korea (NRF-2020M3A9G7103934)

  • Ji-Joon Song

National Research Foundation of Korea (NRF-2020M3A9G7103934)

  • Weontae Lee

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2022, Heo et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,124
    views
  • 508
    downloads
  • 13
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yunseok Heo
  2. Eojin Yoon
  3. Ye-Eun Jeon
  4. Ji-Hye Yun
  5. Naito Ishimoto
  6. Hyeonuk Woo
  7. Sam-Yong Park
  8. Ji-Joon Song
  9. Weontae Lee
(2022)
Cryo-EM structure of the human somatostatin receptor 2 complex with its agonist somatostatin delineates the ligand binding specificity
eLife 11:e76823.
https://doi.org/10.7554/eLife.76823

Share this article

https://doi.org/10.7554/eLife.76823

Further reading

    1. Structural Biology and Molecular Biophysics
    Yuanyuan Wang, Fan Xu ... Yongning He
    Research Article

    SCARF1 (scavenger receptor class F member 1, SREC-1 or SR-F1) is a type I transmembrane protein that recognizes multiple endogenous and exogenous ligands such as modified low-density lipoproteins (LDLs) and is important for maintaining homeostasis and immunity. But the structural information and the mechanisms of ligand recognition of SCARF1 are largely unavailable. Here, we solve the crystal structures of the N-terminal fragments of human SCARF1, which show that SCARF1 forms homodimers and its epidermal growth factor (EGF)-like domains adopt a long-curved conformation. Then, we examine the interactions of SCARF1 with lipoproteins and are able to identify a region on SCARF1 for recognizing modified LDLs. The mutagenesis data show that the positively charged residues in the region are crucial for the interaction of SCARF1 with modified LDLs, which is confirmed by making chimeric molecules of SCARF1 and SCARF2. In addition, teichoic acids, a cell wall polymer expressed on the surface of gram-positive bacteria, are able to inhibit the interactions of modified LDLs with SCARF1, suggesting the ligand binding sites of SCARF1 might be shared for some of its scavenging targets. Overall, these results provide mechanistic insights into SCARF1 and its interactions with the ligands, which are important for understanding its physiological roles in homeostasis and the related diseases.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.